Pfizer working on updated jab in response to Omicron variant: CEO Dr Albert Bourla

Pfizer is now working on an updated jab in response to the Omicron variant that could be ready in 100 days, the report said.

Published: 02nd December 2021 04:50 PM  |   Last Updated: 02nd December 2021 04:50 PM   |  A+A-

Pfizer COVID-19 booster

For representational purposes (Photo | AP)


LONDON: Pfizer is working on an updated jab in response to the Omicron variant that could be ready in 100 days, according to the head of American multinational pharmaceutical giant, who said that people may need to have annual Covid-19 vaccinations for many years to come.

Pfizer's chief executive Dr Albert Bourla told the BBC that he is of the view that annual vaccinations would be needed to maintain a "very high level of protection" against the deadly disease that has claimed over five million lives across the world.

Bourla was speaking to the BBC before the emergence of the Omicron variant, first identified in South Africa and also before the announcement that the UK government had signed contracts to buy the 54 million additional Pfizer-BioNTech and 60 million Moderna doses for 2022 and 2023.

These deals include access to modified vaccines if needed to combat Omicron and future variants of concern, the Department of Health has said.

Dr Bourla said Pfizer had already made updated vaccines in response to the Beta, also first identified in South Africa, and Delta, first identified in India, variants but that they had not been needed.

The company is now working on an updated jab in response to the Omicron variant that could be ready in 100 days, the report added.

He said vaccines had helped save millions of lives during the pandemic, and without them, the "fundamental structure of our society would be threatened".

By the end of the year, Pfizer expects to have supplied three billion doses of its messenger ribonucleic-acid (mRNA) vaccine with four billion planned for next year.

There had been a global race to protect people, Dr Bourla said, but in 2022, countries would have "as many doses as they need".

Having to be stored at -70C, the Pfizer vaccine has been tricky to deploy in countries with limited health services.

But within a month or so, Pfizer says it will roll out a new formulation of the vaccine that can be stored for three months in a fridge, which Dr Bourla said, would make a "huge difference" for sub-Saharan African countries.

He also talked about vaccine hesitancy.

"For those that are just afraid, the only emotion of human beings stronger than fear is love," he said.

"So I am always using this argument that the decision to get another vaccine is not going to influence only your health, it is going to affect the health of others and particularly the health of the people you love the most because they are the ones that you will interact with.

"So take the courage to overcome your fears and do the right thing."

The total tally of COVID-19 cases and deaths globally now stands at 263,565,559 and 5,225,667 respectively.

Total vaccine doses administered globally are 8,041,107,778, according to Johns Hopkins University.


Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on are those of the comment writers alone. They do not represent the views or opinions of or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp